Expansion of PET diagnostics business opportunities - James McBrayer, CEO, Cyclopharm Ltd 00:00:00

Share On Facebook Share On Twitter

Cyclopharm Limited (ASX:CYC) Managing Director and CEO, James McBrayer talks about the company's joint venture to expand Positron Emission Tomography (PET) diagnostics business opportunities for NSW and Australia.

Recent Videos